PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 87 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.91 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $260,835 | +35.8% | 118,025 | +56.0% | 0.00% | – |
| Q1 2023 | $192,128 | +124.3% | 75,641 | +65.1% | 0.00% | – |
| Q4 2022 | $85,659 | -76.1% | 45,807 | -67.2% | 0.00% | – |
| Q3 2022 | $359,000 | +20.5% | 139,559 | -9.6% | 0.00% | – |
| Q2 2022 | $298,000 | +14.6% | 154,384 | +76.2% | 0.00% | – |
| Q1 2022 | $260,000 | -90.4% | 87,638 | -85.5% | 0.00% | – |
| Q4 2021 | $2,718,000 | +32.1% | 605,160 | +42.9% | 0.00% | – |
| Q3 2021 | $2,057,000 | +33.7% | 423,468 | +87.6% | 0.00% | – |
| Q2 2021 | $1,539,000 | +87.7% | 225,742 | +94.3% | 0.00% | – |
| Q1 2021 | $820,000 | -77.4% | 116,196 | -80.0% | 0.00% | – |
| Q4 2020 | $3,632,000 | +127.6% | 580,288 | +96.8% | 0.00% | – |
| Q3 2020 | $1,596,000 | +74.4% | 294,922 | +68.1% | 0.00% | – |
| Q2 2020 | $915,000 | +110.3% | 175,459 | +27.1% | 0.00% | – |
| Q1 2020 | $435,000 | -54.6% | 138,008 | -42.0% | 0.00% | – |
| Q4 2019 | $959,000 | +0.8% | 238,129 | +8.2% | 0.00% | – |
| Q3 2019 | $951,000 | +167.9% | 220,014 | +147.5% | 0.00% | – |
| Q2 2019 | $355,000 | +26.3% | 88,878 | +69.3% | 0.00% | – |
| Q1 2019 | $281,000 | -48.3% | 52,500 | -50.5% | 0.00% | – |
| Q4 2018 | $544,000 | -73.4% | 106,049 | -49.7% | 0.00% | -100.0% |
| Q3 2018 | $2,045,000 | -12.6% | 210,810 | -8.2% | 0.00% | – |
| Q2 2018 | $2,341,000 | +7.7% | 229,606 | +37.3% | 0.00% | – |
| Q1 2018 | $2,174,000 | -48.0% | 167,265 | -28.3% | 0.00% | -100.0% |
| Q4 2017 | $4,178,000 | -46.8% | 233,395 | -25.3% | 0.00% | -66.7% |
| Q3 2017 | $7,847,000 | -0.3% | 312,609 | -4.3% | 0.00% | 0.0% |
| Q2 2017 | $7,873,000 | +133.3% | 326,700 | +86.4% | 0.00% | +200.0% |
| Q1 2017 | $3,374,000 | +213.0% | 175,300 | +150.3% | 0.00% | – |
| Q4 2016 | $1,078,000 | +385.6% | 70,037 | +309.6% | 0.00% | – |
| Q3 2016 | $222,000 | +32.1% | 17,100 | +41.3% | 0.00% | – |
| Q2 2016 | $168,000 | -52.1% | 12,100 | +7.6% | 0.00% | – |
| Q1 2015 | $351,000 | +71.2% | 11,244 | +111.4% | 0.00% | – |
| Q4 2014 | $205,000 | – | 5,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |